Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
2.390
-0.110 (-4.40%)
At close: Dec 5, 2025, 4:00 PM EST
2.450
+0.060 (2.51%)
After-hours: Dec 5, 2025, 6:59 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Point-of-care Testing, Low-dose Interferon Alpha Therapeutics and Synthetic RNA-driven preventative Medicine
20.73K
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing, Low-dose Interferon Alpha Therapeutics and Synthetic RNA-driven preventative Medicine Growth
-83.02%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
United States
20.73K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-83.02%
Log In
Log In
Log In
Log In
Upgrade